What is MCK stock price today?

MCK (Mckesson Corp) stock is trading at $742.44 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is MCK stock going up or down today?

MCK stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy MCK stock now?

The decision to buy MCK depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is MCK a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for MCK based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is MCK stock overvalued or undervalued?

MCK currently trades at a P/E ratio of 19.65 relative to earnings. Our DCF calculator provides intrinsic value estimates to help determine if MCK is fairly priced.

What is MCK's P/E ratio?

MCK has a price-to-earnings (P/E) ratio of 19.65, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.

What is MCK's market cap?

MCK (Mckesson Corp) has a market capitalization of $90.68 billion, making it a mid-cap stock.

What is MCK's price to book ratio?

MCK trades at a price-to-book (P/B) ratio of 5.04, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does MCK pay dividends?

Yes, MCK pays dividends with a current yield of 0.00%. Dividend payments provide income for investors in addition to potential stock price appreciation.

What is MCK's dividend yield?

MCK's dividend yield is 0.00%, calculated as annual dividends divided by the current stock price. This represents the annual return from dividends alone.

Is MCK stock a good long-term investment?

MCK's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is MCK's revenue growth rate?

MCK has shown revenue growth of 0.1% over recent periods. Consistent revenue growth is a key indicator of business health and competitive positioning.

Yes, MCK is profitable with a profit margin of 0.0%. This indicates the company generates 0.0 cents of profit for every dollar of revenue.

What are the risks of investing in MCK?

Key risks for MCK include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does MCK compare to its competitors?

Compare MCK to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize MCK's performance and positioning.

What is MCK's stock price target for 2026?

Our AI model provides price targets for MCK based on fundamental analysis: Bull case $965.17 (+30%), Base case $853.81 (+15%), Bear case $668.20 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about MCK?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for MCK. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is MCK's next earnings report?

MCK reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

MCK - Mckesson Corp

NYSE * Health Care * Health Care Providers & Services

$742.44

$-14.54 (-1.92%)

About Mckesson Corp

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; delivers products to retail pharmacies, hospitals, long-term care centers, clinics, and institutions; and provides logistics and distribution services for manufacturers. It also provides consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies; gene therapy with InspiroGene, practice consulting, and vaccine distribution services; and technology solutions, as well as research, insights, technologies, and services to improve cancer and specialty care. In addition, the company helps in solving medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. Further, it offers technology services, which includes electronic prior authorization, prescription price transparency, benefit insight, dispensing support services, patient enrollment, third-party logistics, and wholesale distribution support; medical-surgical supplies, laboratory equipment, pharmaceutical distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, and hospital reference labs, nursing homes, hospice and home health care agencies, government facilities ,and online marketplaces and retailers. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

MCK Key Statistics

Market Cap

$90.68B

P/E Ratio

19.65

P/B Ratio

5.04

EPS

$38.40

Dividend Yield

0.00%

Revenue Growth

+0.1%

Profit Margin

0.0%

Employees

41,600

How MCK Compares to Peers

MCK has the lowest P/E ratio in Health Care Providers & Services, suggesting it may be the most undervalued

MCK is the smallest among peers, which may offer higher growth potential

P/E Rank

of 2

Margin Rank

of 2

Growth Rank

of 2

Size Rank

of 2

Company	Market Cap	P/E	Growth	Margin	Compare
MCK(This stock)	$90.68B	19.6	0%	0.0%	-
AMZNAmazon Com	$2.92T	31.6	0%	0.1%	vs AMZN

Mckesson Corp Company Information

Headquarters: Texas; U.S.A
Website: www.mckesson.com
Sector: Health Care
Industry: Health Care Providers & Services

MCK - Mckesson Corp

About Mckesson Corp

MCK Key Statistics

How MCK Compares to Peers

Mckesson Corp Company Information

MCK Lician Score

MCK Financial Snowflake

Upcoming Events for MCK